- Research article
- Open Access
- Open Peer Review
Algorithms for optimizing drug therapy
© Wanger and Martin; licensee BioMed Central Ltd. 2004
- Received: 31 March 2004
- Accepted: 20 July 2004
- Published: 20 July 2004
Drug therapy has become increasingly efficient, with more drugs available for treatment of an ever-growing number of conditions. Yet, drug use is reported to be sub optimal in several aspects, such as dosage, patient's adherence and outcome of therapy. The aim of the current study was to investigate the possibility to optimize drug therapy using computer programs, available on the Internet.
Three types of algorithms were sufficient for the intended purpose. The simplest type is a list of factors, each of which implies that the particular patient should or should not receive treatment. This is adequate in situations where only one treatment exists. The second type, a more elaborate model, is required when treatment can by provided using drugs from different pharmacological classes and the selection of drug class is dependent on patient characteristics. An easily implemented set of if-then statements was able to manage the identified information in such instances. The third type was needed in the few situations where the selection and dosage of drugs were depending on the degree to which one or more patient-specific factors were present. In these cases the implementation of an established decision model based on fuzzy sets was required. Computer programs based on one of these three models could be constructed regarding all but one of the studied disorders. The single exception was depression, where reliable relationships between patient characteristics, drug classes and outcome of therapy remain to be defined.
Algorithms for optimizing drug therapy can, with presumably rare exceptions, be developed for any disorder, using standard Internet programming methods.
- Drug Class
- Computerize Physician Order Entry
- Radio Button
- Optimize Drug Therapy
- Swedish Medical Product Agency
During the last decades the possibility of computer support for optimum management of various disorders has attracted interest [1–3]. Regarding drug therapy the approach has usually been limited to one particular disease [4–7]. Diabetes has been extensively studied and thoroughly analyzed also from a systems perspective . Several attempts have been made to develop a general model for medical guidelines, which could be used also for the development of computer programs [9–12]. Computerized physician order entry has been shown to reduce the frequency of serious medication errors. Decision support tools such as alerting functions for patient medication allergy are a key part of these applications. However, Abookire and co-workers  analyzed trend data obtained over a five-year period that showed decreasing compliance to allergy alert functions within computerized order entry. They concluded that optimal performance requires iterative refinement and that, as systems become increasingly complex, mechanisms to monitor their performance become increasingly critical . In another study large differences were seen for all main types of medication errors: dose errors, frequency errors, route errors, substitution errors, and allergies . In a university hospital setting, the reductions in transcription errors and medication turn-around times supported the view that computerized physician order entry and an electronic medication administration record can provide a good return on investment .
In the current study guidelines for 246 diseases were analyzed regarding the content of facts, and relationships between these facts, influencing the selection and dosage of therapeutic drugs. The aim of study was to identify one or more algorithms (descriptions of how to solve a problem in a definite number of steps), which could be used to support optimum drug therapy in any disease.
The studied material consisted of 110 officially endorsed text documents, published between 1996 and 2004. Forty-four of these documents were published by the Swedish Medical Products Agency , 13 by the Swedish Agency for Evaluation of Medical Technologies  and 53 (in three booklets) by the Swedish Strategic Programme for The Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA) , established in order to prevent bacterial resistance to common antibiotics. The documents contained guidelines for drug therapy in altogether 246 disorders. Information regarding contraindications, dosage etc was available from an existing pharmaceutical website  and was retrieved by linking to context-relevant pages.
These documents were analyzed as follows: All statements in the particular document regarding patient-, disease- and drug-related factors were recorded. In a second step the statements in the texts describing the relationship between these factors were identified. After that the obtained information was rewritten in a format similar to a generic computer language, using if-then statements and logical operators as needed. These rewritten documents were grouped according to similarity in structure, based on the number of if-then statements, the need for branching or calculations in the code and the occurrence of 'left-overs', i.e. information in the text that could not be explicitly expressed using if-then statements and logical operators. In theory this procedure could result in an intractable combinatorial explosion. This was observed only in one situation, regarding side effects of anti-hypertensive medication.
Figure 1 shows the number of facts, relevant for the selection of appropriate drug class in the 246 studied diseases. Three algorithms were sufficient for the intended purpose. The simplest model is a list, containing the data, which imply that the patient should or should not receive a particular treatment. This model is adequate in situations where only one pharmacological treatment modality exists, such as influenza, where neuramidase inhibitors are the only drug class approved in Sweden, see figure 2. A 16 page summary of 35 pages of background documentation contained the following data items influencing drug therapy: four risk groups, time from start of symptom, two available neuramidases, one of which was approved also for use in children. Pharmaceutical properties regarding all approved drugs is available online (accessed from the program using 'deep linking'). In the actual program implementation information was added about current epidemiological state regarding influenza by linking to a government authority website, diagnostic criteria and some management aspects (in pop-up windows) (Fig. 2).
The pharmaceutical information about all therapeutics drugs, approved in Sweden, is available on the Internet at a site managed by the association of pharmaceutical industries . By linking to this site, the programs provide access to the relevant and continously updated drug information regarding all drugs, registered for use in the current disease. In addition, each program is linked to the appropriate guideline document, so that the user can verify the program's treatment advice.
The main findings in the current study are that simple algorithms can support drug therapy and that such algorithms can be easily implemented using standard Internet programming techniques. Problems in the implementation of information system designed to support actual care are discussed in a study by Bates et. al. . The authors concluded that 'ten commandments' have to be taken into account. The most important factors for success were speed, anticipation of needs and good fit into the user's workflow. The programs developed in the current study easily meet these criteria, provided that the users have access to the Internet. However, it should be noted that the programs require no communication of patient-related information over the Internet, other than transmission of the prescription to the pharmacy, if such a system is implemented.
One disorder, depression, was identified for which relevant computer program support could not be constructed. Initially, the program model with the above-mentioned decision algorithm, based on fuzzy sets, was thought to be applicable, since the number of relevant facts is well within manageable range; four major classes of drugs, slightly more than ten diagnostic variables, some ten receptors and seven neurotransmitters. However, the information in the official consensus document , did not provide sufficient information, due to the lack of explicit relationships between the patient's characteristics, as described e.g. by diagnostic rating scales, and the pharmacological properties of the various types of antidepressants. Outcome studies regarding depression also give little information about which drug should be recommended for a particular patient. The exception is a recent report by Joyce et al , who found a markedly superior response to nortriptyline compared to fluoxetine in men above 40 years of age, and the reverse effect in women, aged 18 – 24 years.
Problems in pharmacotherapy related to the simultaneous occurrence of multiple disorders in the same patient are well studied and presented in the pharmacological information as contraindications or recommendations of "caution in patients with disease ...". This information is used as output from the programs in the current study.
The introduction of a new drug for treatment of a particular disease, or the results from new scientific studies may have considerable influence on guidelines. Yet only a few documents were changed during the study period and the lifespan of pharmacotherapeutic guidelines can be assumed to be 2–5 years. However, new information may appear unexpectedly, and a reasonably complete system for pharmacotherapy requires frequent updates. The approach taken in the current study, with the programs stored on a website as scripted HTML pages, facilitates the maintenance and update of the system and ensures that all users always have access to the latest version. An additional way to increase relevance over time is to link from the programs to recently published studies, e.g. by providing automatic searches in the PubMed database .
In summary, algorithms for optimizing drug therapy can, with presumably rare exceptions, be developed for any disorder using standard Internet programming methods.
- Montani S, Bellazzi R, Quaglini S, d'Annunzio G: Meta-analysis of the effect of the use of computer-based systems on the metabolic control of patients with diabetes mellitus. Diabetes Technol Ther. 2001, 3: 347-56. 10.1089/15209150152607123.View ArticlePubMedGoogle Scholar
- Blackshear JL, Schwartz GL: Step care therapy for hypertension in diabetic patients. Mayo Clin Proc. 2001, 76: 266-74.View ArticleGoogle Scholar
- Schmidt R, Gierl L: Case-based reasoning for antibiotics therapy advice: an investigation of retrieval algorithms and prototypes. Artif Intell Med. 2001, 23: 171-86. 10.1016/S0933-3657(01)00083-5.View ArticlePubMedGoogle Scholar
- Wanger P, Martin L: Computer-assisted management of patients with open-angle glaucoma or ocular hypertension. Acta Ophthalmol. 1997, 75: 700-704.View ArticleGoogle Scholar
- Martin L, Wanger P: Prescription of anti-glaucoma drugs, patient characteristics and treatment results. 3rd International Glaucoma Symposium, Prag, Mars. 2001, (accessed 2004-05-28), [http://www.ste.ki.se/of/glaucomaX/prahaposter.pdf]Google Scholar
- Wanger P, Martin L: Evaluation of a computerized decision-support system for managing patients with high blood pressure [abstract]. J Hypertension. 2001, 19: s226-Google Scholar
- Seroussi B, Bouaud J, Dreau H, Falcoff H, Riou C, Joubert M, Simon C, Simon G, Venot A: ASTI: a guideline-based drug-ordering system for primary care. Medinfo. 2001, 10 (Pt 1): 528-32.Google Scholar
- Carson ER: Decision support systems in diabetes: a systems perspective. Comput Methods Programs Biomed. 1998, 56: 77-91. 10.1016/S0169-2607(98)00017-0.View ArticlePubMedGoogle Scholar
- PROFORMA. (accessed 2004-06-13), [http://www.acl.icnet.uk/lab/proforma.html]
- Prodigy. (accessed 2004-06-13), [http://www.prodigy.nhs.uk/]
- Dufour J-C, Fieschi D, Fieschi M: Coupling computer-interpretable guidelines with a drug-database through a web-based system – The PRESGUID project. BMC Medical Informatics and Decision Making. 2004, 4: 2-10.1186/1472-6947-4-2.View ArticlePubMedPubMed CentralGoogle Scholar
- Schiffman RN, Karras BT, Agrawal A, Chen R, Marenco L, Nath S: GEM: A proposal for a more comprehensive guideline document model using XML. J Am Med Inform Assoc. 2000, 7: 488-498.View ArticleGoogle Scholar
- Abookire SA, Teich JM, Sandige H, Paterno MD, Martin MT, Kuperman GJ, Bates DW: Improving allergy alerting in a computerized physician order entry system. In: Proc AMIA Symp. 2000, 2-6.Google Scholar
- Bates DW, Teich JM, Lee J, Seger D, Kuperman GJ, Ma'Luf N, Boyle D, Leape L: The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc. 1999, 6: 313-21.View ArticlePubMedPubMed CentralGoogle Scholar
- Mekhjian HS: Immediate benefits realized following implementation of physician order entry at an academic medical center. J Am Med Inform Assoc. 2002, 9: 529-539. 10.1197/jamia.M1038.View ArticlePubMedPubMed CentralGoogle Scholar
- Swedish Medical Products Agency. (accessed 2004-05-28), [http://www.mpa.se]
- Swedish Agency for Evaluation of Medical Technologies. (accessed 2004-05-28), [http://www.sbu.se]
- Strategy Group for Rational Use of Antibiotics. (accessed 2004-05-28), [http://www.strama.se]
- Swedish Association of Pharmaceutical Manufacturers. (accessed 2004-05-28), [http://www.fass.se]
- Heart Failure Treatment Guide. (accessed 2004-05-28), [http://www.ste.ki.se/of/lm/heart/]
- Giarratano J, Riley G: Expert Systems, Principles and Programming. 1998, PWS Publishing Company Boston, ThirdGoogle Scholar
- Yager RR: A New Methodology for Ordinal Multiple Aspect Decisions Based on Fuzzy Sets. Decision Sciences. 1981, 12: 589-600.View ArticleGoogle Scholar
- Demo of ordinal multiple aspects decision algorithm. (accessed 2004-05-28), [http://www.ste.ki.se/of/lm/dgkodjs.htm]
- Kjellgren KI, Ahlner J, Dahllöf B, Gill H, Hedner T, Säljö R: Perceived symptoms among hypertensive patients in routine clinical practise – a population-based study. J Intern Med. 1998, 244 (4): 325-32. 10.1046/j.1365-2796.1998.00377.x.View ArticlePubMedGoogle Scholar
- Bates DW, Kupferman GJ, Wang S, Gandhi T, Kittler A, Volk L, Spurr C, Khorasani R, Tanasijevic M, Middleton B: Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J Am Med Inform Assoc. 2000, 10: 6-Google Scholar
- Swedish Agency for Evaluation of Medical Technologies. (accessed 2004-05-28), [http://www.sbu.se/Filter/Content1/Dokument/SBU_depression_eng.pdf]
- Joyce PR, Mulder RT, Luty SE, McKenzie JM, Rae AM: A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender. Acta Psychiatr Scand. 2003, 108: 20-23. 10.1034/j.1600-0447.2003.00120.x.View ArticlePubMedGoogle Scholar
- PubMed. (accessed 2004-05-28), [http://www.ncbi.nlm.nih.gov/entrez/]
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6947/4/10/prepub
This article is published under license to BioMed Central Ltd. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.